keyword
Keywords Cognitive dysfunction in cance...

Cognitive dysfunction in cancer patients

https://read.qxmd.com/read/38676932/neurodegenerative-disease-pathways-are-perturbed-in-patients-with-cancer-who-self-report-cognitive-changes-and-anxiety-a-pathway-impact-analysis
#1
JOURNAL ARTICLE
Kate R Oppegaard, Samantha J Mayo, Terri S Armstrong, Vasuda Dokiparthi, Michelle Melisko, Jon D Levine, Adam B Olshen, Joaquin A Anguera, Ritu Roy, Steven Paul, Bruce Cooper, Yvette P Conley, Marilyn J Hammer, Christine Miaskowski, Kord M Kober
BACKGROUND: Cancer-related cognitive impairment (CRCI) and anxiety co-occur in patients with cancer. Little is known about mechanisms for the co-occurrence of these two symptoms. The purposes of this secondary analysis were to evaluate for perturbed pathways associated with the co-occurrence of self-reported CRCI and anxiety in patients with low versus high levels of these two symptoms and to identify potential mechanisms for the co-occurrence of CRCI and anxiety using biological processes common across any perturbed neurodegenerative disease pathways...
April 27, 2024: Cancer
https://read.qxmd.com/read/38671933/potential-of-natural-phenolic-compounds-against-doxorubicin-induced-chemobrain-biological-and-molecular-mechanisms-involved
#2
REVIEW
Simona Serini, Gabriella Calviello
Chemotherapy-induced cognitive impairment or "chemobrain" is a prevalent long-term complication of chemotherapy and one of the more devastating. Most of the studies performed so far to identify the cognitive dysfunctions induced by antineoplastic chemotherapies have been focused on treatment with anthracyclines, frequently administered to breast cancer patients, a population that, after treatment, shows a high possibility of long survival and, consequently, of chemobrain development. In the last few years, different possible strategies have been explored to prevent or reduce chemobrain induced by the anthracycline doxorubicin (DOX), known to promote oxidative stress and inflammation, which have been strongly implicated in the development of this brain dysfunction...
April 18, 2024: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/38668912/a-systematic-review-of-cognitive-impairment-in-individuals-with-colorectal-cancer
#3
JOURNAL ARTICLE
Ye Wang, Zhiming Wang, Rongyu Li, Zheng Sun, Yi Zhang, Qiuping Li
PROBLEM IDENTIFICATION: Patients with colorectal cancer (CRC) encounter varying degrees of objective and subjective cognitive impairment. The prevalence of objective and subjective cognitive impairment, factors affecting cognitive impairment, and interventions are presented in this review. LITERATURE SEARCH: The CINAHL Plus®, Cochrane Library, Embase®, PsycINFO®, PubMed®, and CNKI databases were systematically searched from the time of the database's establishment to May 2023...
April 18, 2024: Oncology Nursing Forum
https://read.qxmd.com/read/38668911/self-reported-cancer-related-cognitive-impairment-in-patients-with-breast-cancer-is-associated-with-potassium-channel-gene-polymorphisms
#4
JOURNAL ARTICLE
Kate R Oppegaard, Marilyn J Hammer, Yvette P Conley, Carolyn S Harris, Bruce A Cooper, Steven M Paul, Joosun Shin, Lisa Morse, Gary M Abrams, Jon D Levine, Christine Miaskowski
OBJECTIVES: To evaluate for associations of polymorphisms for potassium channel genes in patients with breast cancer who were classified as having high or low-moderate levels of cancer-related cognitive impairment (CRCI). SAMPLE & SETTING: 397 women who were scheduled to undergo surgery for breast cancer on one breast were recruited from breast care centers located in a comprehensive cancer center, two public hospitals, and four community practices. METHODS & VARIABLES: CRCI was assessed using the Attentional Function Index prior to and for six months after surgery...
April 18, 2024: Oncology Nursing Forum
https://read.qxmd.com/read/38653573/a-randomized-clinical-trial-efficacy-of-group-based-acceptance-and-commitment-therapy-program-for-breast-cancer-patients-with-high-fear-of-progression
#5
RANDOMIZED CONTROLLED TRIAL
Fatemeh Hassani Alimolk, Fiona Elizabeth Jean McDonald, Mohammad Asghari-Jafarabadi, Farzane Ahmadi, Saeedeh Zenoozian, Marzieh Lashkari, Pandora Patterson
BACKGROUND: Fear of progression (FOP) is a common and significant concern among cancer patients, encompassing worries about cancer progression during active treatment. Elevated levels of FOP can be dysfunctional. This study aims to assess the efficacy of an Acceptance and Commitment Therapy (ACT)-based intervention on FOP, anxiety sensitivity (AS), and quality of life (QOL) in breast cancer patients. METHODS: A clinical trial was conducted involving 80 stage I-III active-treatment breast cancer patients with a score greater than 34 on the Fear of Progression Questionnaire-Short Form scale...
April 2024: Psycho-oncology
https://read.qxmd.com/read/38639810/functional-quality-of-life-among-newly-diagnosed-young-adult-colorectal-cancer-survivors-compared-to-older-adults-results-from-the-colocare-study
#6
JOURNAL ARTICLE
Laura B Oswald, Amanda Bloomer, Xiaoyin Li, Esther Jean-Baptiste, Gillian Trujillo, Seth Felder, Brent J Small, Jennifer Ose, Sheetal Hardikar, Ildiko Strehli, Lyen C Huang, Kathi Mooney, Matthew G Mutch, Dante Chao, Stacey A Cohen, Meghana Karchi, Elizabeth H Wood, Victoria Damerell, Nicole C Loroña, Jun Gong, Adetunji T Toriola, Christopher I Li, David Shibata, Martin Schneider, Biljana Gigic, Jane C Figueiredo, Heather S L Jim, Cornelia M Ulrich, Erin M Siegel
PURPOSE: Colorectal cancer (CRC) incidence and mortality are increasing among young adults (YAs) aged 18-39. This study compared quality of life (QOL) between YA and older adult CRC survivors in the ColoCare Study. METHODS: Participants were grouped by age (years) as follows: 18-39 (YA), 40-49, 50-64, and 65 + . Functional QOL (physical, social, role, emotional, cognitive) and global QOL were assessed with the EORTC-QLQ-C30 at enrollment, 3, 6, and 12 months...
April 19, 2024: Supportive Care in Cancer
https://read.qxmd.com/read/38632872/spiritual-interventions-improving-the-lives-of-colorectal-cancer-survivors-a-systematic-literature-review
#7
REVIEW
Calixtus Abiodun Okere, Tarja Kvist, Natalia Sak-Dankosky, Victor Yerris
AIM: To systematically review the types of spiritual interventions available for colorectal cancer survivors and determine if they improve their lives. DESIGN: Systematic review. DATA SOURCE: A thorough literature search was conducted in July 2023 using PRIMO, PubMed/Medline, Cochrane, CINAHL, Scopus, and EMBASE. REVIEW METHODS: As an extension of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) checklist, the Synthesis Without Meta-Analysis reporting guideline was employed...
April 17, 2024: Journal of Advanced Nursing
https://read.qxmd.com/read/38596664/sexual-experiences-and-information-needs-among-patients-with-prostate-cancer-a-qualitative-study
#8
JOURNAL ARTICLE
Zhou Haining, Zhang Xiaoli, Zhu Jiping, Zhang Beibei, Meng Ping, Guo Yunfei
BACKGROUND: Less is known about the sexual life and information seeking of Chinese patients with prostate cancer (PCa) after androgen deprivation therapy (ADT) treatment. AIM: To identify the experiences of sex and information needs among Chinese patients with PCa after ADT treatment. METHODS: This qualitative study included 15 Chinese patients with PCa in urology inpatient wards, selected via a purposive sampling method. Semistructured interviews were conducted face-to-face or by telephone regarding sexual experiences and information needs after ADT treatment...
April 2024: Sexual Medicine
https://read.qxmd.com/read/38584828/postoperative-cognitive-dysfunction-in-elderly-patients-with-colorectal-cancer-a-randomized-controlled-study-comparing-goal-directed-and-conventional-fluid-therapy
#9
JOURNAL ARTICLE
Bin Wu, Yuanyuan Guo, Su Min, Qiuju Xiong, Lei Zou
To investigate the impact of goal-directed fluid therapy (GDFT) on postoperative cognitive dysfunction (POCD) in elderly patients with colorectal cancer, we conducted a randomized controlled trial. Eighty elderly patients who underwent elective laparoscopic radical resection of colorectal cancer were randomly assigned to either the GDFT group or the conventional fluid therapy group. The primary outcome was the incidence of POCD during the initial 7 postoperative days, while secondary outcomes included inflammatory marker levels such as interleukin-6 (IL-6) and S100β protein, hemodynamics, level of lactic acid, postoperative functional recovery, and complications...
2024: Open Medicine (Warsaw, Poland)
https://read.qxmd.com/read/38581957/the-association-of-chemotherapy-induced-peripheral-neuropathy-with-reduced-executive-function-in-chemotherapy-treated-cancer-survivors-a-cross-sectional-study
#10
JOURNAL ARTICLE
Brendan L McNeish, Kim Dittus, Jurdan Mossburg, Nicholas Krant, John A Steinharter, Kendall Feb, Hunter Cote, Michael K Hehir, Rebecca Reynolds, Mark S Redfern, Caterina Rosano, James K Richardson, Noah Kolb
INTRODUCTION: Chemotherapy-induced peripheral neuropathy (CIPN) is common and disabling among cancer survivors. Little is known about the association of CIPN with other measures of the nervous system's integrity, such as executive dysfunction. We compared measures of executive function in older chemotherapy-treated cancer survivors with and without CIPN. MATERIALS AND METHODS: This cross-sectional study enrolled 50 chemotherapy-treated cancer survivors (65.6 ± 11...
April 5, 2024: Journal of Geriatric Oncology
https://read.qxmd.com/read/38538780/psychosocial-consequences-of-head-and-neck-cancer-symptom-burden-after-chemoradiation-a-mixed-method-study
#11
JOURNAL ARTICLE
Carley Geiss, Aasha I Hoogland, Brandy Arredondo, Yvelise Rodriguez, Crystal Bryant, Christine H Chung, Krupal B Patel, Brian D Gonzalez, Heather S L Jim, Kedar Kirtane, Laura B Oswald
PURPOSE: Patients with head and neck cancer (HNC) experience significant symptom burden from combination chemotherapy and radiation (chemoradiation) that affects acute and long-term health-related quality of life (HRQOL). However, psychosocial impacts of HNC symptom burden are not well understood. This study examined psychosocial consequences of treatment-related symptom burden from the perspectives of survivors of HNC and HNC healthcare providers. METHODS: This was a cross-sectional, mixed-method study conducted at an NCI-designated comprehensive cancer center...
March 27, 2024: Supportive Care in Cancer
https://read.qxmd.com/read/38516716/the-link-between-the-early-surgery-induced-inflammatory-response-and-postoperative-cognitive-dysfunction-in-older-patients
#12
JOURNAL ARTICLE
Baukje Brattinga, Matthijs Plas, Jacoba M Spikman, Abraham Rutgers, Jacco J de Haan, Hanneke van der Wal-Huisman, Anthony R Absalom, Gertrude J Nieuwenhuijs-Moeke, Barbara C van Munster, Geertruida H de Bock, Barbara L van Leeuwen
BACKGROUND: Postoperative cognitive dysfunction (POCD) is a common complication in older patients with cancer and is associated with decreased quality of life and increased disability and mortality rates. Systemic inflammation resulting in neuroinflammation is considered important in the pathogenesis of POCD. The aim of this study was to explore the association between the early surgery-induced inflammatory response and POCD within 3 months after surgery in older cancer patients...
March 22, 2024: Journal of the American Geriatrics Society
https://read.qxmd.com/read/38482990/ligand-gated-ion-channels-as-potential-biomarkers-for-adt-mediated-cognitive-decline-in-prostate-cancer-patients
#13
JOURNAL ARTICLE
Shiv Verma, Vaibhav Singh, VijayKrishna Nagampalli, Lee E Ponsky, Chiang-Shan R Li, Herta Chao, Sanjay Gupta
Men with prostate cancer are at increased risk of developing cognitive decline by the use of second-generation androgen signaling inhibitors. To date, reliable and sensitive biomarkers that could distinguish men at high risk of cognitive dysfunction under androgen deprivation therapy (ADT) have not been characterized. We used high-throughput transcriptional profiling utilizing human prostate cancer cell culture models mimicking ADT, biomarker selection using minimal common oncology data elements-cytoscape, and bioinformatic analyses employing Advaita® iPathwayGuide and DisGeNET for identification of disease-related gene associations...
March 14, 2024: Molecular Carcinogenesis
https://read.qxmd.com/read/38481553/peripheral-pulse-harmonic-analysis-and-its-clinical-application-a-systematic-review
#14
JOURNAL ARTICLE
Kun-Yuan Hsiao, Jiunn-Horng Kang, Yeong-Shing Wu, Hen-Hong Chang, Cheng-Ta Yang
INTRODUCTION: Pulse harmonic analysis is a quantitative and objective methodology within traditional Chinese medicine (TCM) used to evaluate pulse characteristics. However, interpreting pulse wave data is challenging due to its inherent complexity. This study aims to provide a comprehensive review and comparison of existing human pulse wave harmonic analysis methods to elucidate their patterns and characteristics. METHODS: A systematic review of clinical research reports published from 1990 to 2021 was conducted, focusing on variations in harmonic characteristics across different medical conditions and physiological states...
March 2024: Journal of Traditional and Complementary Medicine
https://read.qxmd.com/read/38478329/ovarian-suppression-early-menopause-and-late-effects
#15
REVIEW
Chiara Molinelli, Flavia Jacobs, Guilherme Nader-Marta, Roberto Borea, Graziana Scavone, Silvia Ottonello, Piero Fregatti, Cynthia Villarreal-Garza, Jyoti Bajpai, Hee Jeong Kim, Silvia Puglisi, Evandro de Azambuja, Matteo Lambertini
Around 90% of breast tumours are diagnosed in the early stage, with approximately 70% being hormone receptor-positive. The cornerstone of adjuvant therapy for early-stage hormone receptor-positive breast cancer is endocrine therapy, tailored according to disease stage, biological characteristics of the tumour, patient's comorbidities, preferences and age. In premenopausal patients with hormone receptor-positive breast cancer, ovarian function suppression is a key component of the adjuvant endocrine treatment in combination with an aromatase inhibitor or tamoxifen...
March 13, 2024: Current Treatment Options in Oncology
https://read.qxmd.com/read/38471462/cancer-related-cognitive-dysfunction-a-narrative-review-for-clinical-practice
#16
REVIEW
Oliver Rick, Alexandra Gerhardt, Georgia Schilling
BACKGROUND: Cancer-related cognitive dysfunction (CRCD) is a major functional disorder in patients with cancer. This central nervous dysfunction is found in up to 60 % of patients after tumour therapy, often significantly limits the quality of life and significantly impedes participation in working life. For this reason, diagnosis and treatment of CRCD is of central importance. This narrative review is intended to provide an overview and support for practical clinical care with regard to diagnostics and therapeutic options...
March 12, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38461265/multi-omics-analysis-of-the-gut-microbiome-and-metabolites-associated-with-the-psychoneurological-symptom-cluster-in-children-with-cancer-receiving-chemotherapy
#17
JOURNAL ARTICLE
Jinbing Bai, Ronald Eldridge, Madelyn Houser, Melissa Martin, Christie Powell, Kathryn S Sutton, Hye In Noh, Yuhua Wu, Thomas Olson, Konstantinos T Konstantinidis, Deborah W Bruner
BACKGROUND: Children with cancer receiving chemotherapy commonly report a cluster of psychoneurological symptoms (PNS), including pain, fatigue, anxiety, depression, and cognitive dysfunction. The role of the gut microbiome and its functional metabolites in PNS is rarely studied among children with cancer. This study investigated the associations between the gut microbiome-metabolome pathways and PNS in children with cancer across chemotherapy as compared to healthy children. METHODS: A case-control study was conducted...
March 9, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38424123/glypican-4-serum-levels-are-associated-with-cognitive-dysfunction-and-vascular-risk-factors-in-parkinson-s-disease
#18
JOURNAL ARTICLE
Lars Tatenhorst, Fabian Maass, Hannah Paul, Vivian Dambeck, Mathias Bähr, Rosanna Dono, Paul Lingor
Glypicans are biomarkers for various pathologies, including cardiovascular disease, cancer and diabetes. Increasing evidence suggests that glypicans also play a role in the context of neurodegenerative disorders. Initially described as supporting functionality of synapses via glutamate receptors during CNS development, Glypican 4 (GPC-4) also plays a role in the context of dementia via tau hyperphosphorylation in Alzheimer's disease, which is also a co-pathology in Parkinson's disease dementia. However, clinical evidence of circulating GPC-4 in Parkinson's disease (PD) is missing so far...
February 29, 2024: Scientific Reports
https://read.qxmd.com/read/38407951/virtual-reality-based-exercise-rehabilitation-in-cancer-related-dysfunctions-scoping-review
#19
REVIEW
Zhenzhen Su, Liyan Zhang, Xuemin Lian, Miaomiao Guan
BACKGROUND: Virtual reality-based exercise rehabilitation (VRER) is a promising intervention for patients with cancer-related dysfunctions (CRDs). However, studies focusing on VRER for CRDs are lacking, and the results are inconsistent. OBJECTIVE: We aimed to review the application of VRER in patients with CRDs. METHODS: This scoping review was conducted following the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) checklist framework...
February 26, 2024: Journal of Medical Internet Research
https://read.qxmd.com/read/38399534/assessment-of-radiation-dosage-to-the-hippocampi-during-treatment-of-multiple-brain-metastases-using-gamma-knife-therapy
#20
JOURNAL ARTICLE
Maciej Laskowski, Bartłomiej Błaszczyk, Marcin Setlak, Maciej Kuca, Arkadiusz Lech, Kamil Kłos, Adam Rudnik
Background and Objectives: Brain metastases (BMs) pose significant clinical challenges in systemic cancer patients. They often cause symptoms related to brain compression and are typically managed with multimodal therapies, such as surgery, chemotherapy, whole brain radiotherapy (WBRT), and stereotactic radiosurgery (SRS). With modern oncology treatments prolonging survival, concerns about the neurocognitive side effects of BM treatments are growing. WBRT, though widely used for multiple BMs, has recognized neurocognitive toxicity...
January 31, 2024: Medicina
keyword
keyword
61295
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.